Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a patch-level update. This appears to be routine maintenance rather than a substantive change to the page content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label on the page was updated from v3.6.3 to v3.6.4, indicating a deployment or template update behind the scenes. This behind-the-scenes update does not modify study content or user-facing features.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded sponsor context and a direct access point to related resources by introducing the Moffitt Cancer Center Clinical Trials website and sponsor name. A 'Helpful Links Provided by' label now appears to guide users to additional resources.SummaryDifference0.1%

- Check53 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.3, indicating a newer published version of the study details page. This reflects an update in the revision history (likely content or metadata changes) rather than a visible change to the page's substantive content.SummaryDifference0.0%

- Check67 days agoChange DetectedRecruitment status now indicates enrollment is closed. The page adds new helper sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header and revision label to v3.6.0, replacing the prior heading and v3.5.5 reference.SummaryDifference0.4%

- Check74 days agoChange DetectedA new site revision label v3.5.5 has been added, replacing the previous v3.5.4. This update reflects a minor platform release and does not modify the study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.